ADI-42898

N/A

Report date: 2023/01/07 16:59:33

Base Information

Drug NameADI-42898
Drug Alias NameADI-42898
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionVirus internalization inhibitors
TargetsNot applicable
Therapy Area/IndicationsHemorrhagic Fever with Renal Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAdimab LLC
China Registration ClassN/A

Develop Information

Active CompaniesAdimab LLC
Inactive CompaniesN/A
Active IndicationsHemorrhagic Fever with Renal Syndrome
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A